In what amounts to a coup in the medical world, Providence Health Center
unveiled a new piece of heart equipment Friday that has only been installed at
six other hospitals across the globe.
The machine, which assists doctors in performing certain types of cardiac
procedures, such as angioplasty, is making Providence the envy of the nation's
most prestigious hospitals. Dozens of highly regarded institutions are on a
waiting list for the equipment, including Massachusetts General Hospital and
Houston's Methodist Hospital.
"It's very exciting that here in Waco we'll have the opportunity to utilize
this new technology and participate in the development of new technology," said
cardiologist Dr. Albert Shoultz III. "It's such a dramatic change in how we've
approached interventional cardiology. We hope this technology, as it matures,
will allow us to do things we haven't traditionally been able to do. It's a
unique and very rare opportunity for a community our size."
The equipment, called the Niobe Magnetic Navigation System, is at the cutting
edge of science, Providence officials say. Currently, it has two uses. One is
for so-called coronary intervention applications, or procedures that help with
structural problems of the heart such as blocked arteries. Its other application
involves electrophysiology, which deals with the heart's rhythms.
So far, only one other hospital in the world has one of the machines used for
coronary intervention, and only four other U.S. hospitals and one in Europe have
a machine that can perform the electrophysiology tasks.
Providence was able to obtain the machine, which can do both sets of tasks,
because of its affiliation with Ascension Health, the largest network of
nonprofit hospitals in the nation. One of Ascension's divisions is a company
called Ascension Health Venture, which scours the world for emerging
technologies the hospital system thinks are worthy of supporting.
Dr. Joe Cunningham, chief medical officer of Providence Medical Network, is
vice chairman of the venture group. Providence President and CEO Kent A. Keahey
is also on the board.
The venture group decided to invest in the company that produces the machine,
St. Louis-based Stereotaxis, when the federal Food and Drug Administration
approved the equipment for commercial use in January. Since then, Ascension has
built a strong relationship with the company, and that bond — along with
Cunningham's and Keahey's involvement — was enough to land Providence the new
machine.
The price tag for the technology was $1.9 million, Keahey said, but he
stressed that the cost will not be passed on to patients by way of increased
fees. Providence included the cost in its capital budget for the year, he said,
adding that the hospital was about to replace its electrophysiology lab soon
anyway.
For all the prestige that accompanies the new equipment, it resembles a
souped-up video game system. Doctors use a joystick to navigate medical devices
like stents through a patient's body, and three-dimensional images of the heart
are displayed on flat-screen monitors.
The process starts when a patient lies down on a table that is part of the
machine. Then, two computer-controlled magnets that weigh more than two tons
each are moved into position at the sides of the table to create a magnetic
field within the lab.
Once the magnets are in place, cardiologists use the joystick to guide a
device that is inserted through the groin to where they want it to go in the
heart. As soon as the physician clicks on the screen, a tiny magnet attached to
the end of the device moves the device instantaneously.
Before the machine was installed, the process of getting devices to the heart
was tedious, with physicians having to manually "thread" them all the way from
the groin to the heart. Sometimes, it was even impossible if patients' arteries
were curved or oddly shaped. In those cases, which arose about 20 percent of the
time, doctors often had to resort to invasive surgeries like coronary bypass.
The new equipment could eliminate the need for most patients to undergo such
surgeries because it allows physicians to reach areas of the heart they couldn't
before, Cunningham said. Even for the other 80 percent of patients where
navigating the device was not an issue, there will be improvements, he said. The
main one is speed. Already, the hospital has used the machine to perform
procedures in about five minutes that would have taken 60 to 90 minutes before,
he said.
That efficiency, in turn, makes the procedure safer because the risk of
problems, such as infection, decreases as the process becomes shorter,
Cunningham said.
"We are aiming for safer, better, faster," said Charlotte Kent, area director
for Stereotaxis.
Another exciting aspect of the equipment is that its technology can likely be
adapted for procedures in other parts of the body, Cunningham said. For example,
if someone had a liver tumor, doctors might be able to use the machine to
maneuver a device that would go down to the tumor and release a dose of
chemotherapy. Eventually, it might also be used to treat brain blockages and
tumors, he said.
What's even more thrilling, said Providence officials, is that the hospital
will be at the forefront of developing new applications. In connection with the
installation of the equipment, the hospital and Stereotaxis have a research
agreement in which Providence employees will help pioneer new uses for the
technology.
Largely because of that new relationship, Providence also announced Friday
that it has created the M. Brian Aynesworth Research Center. It is named after a
longtime Waco cardiologist who died in 1982.
Providence has been conducting research since the mid-1980s, said director of
cardiology Debbie Kucera. But the new center will be an official department of
the hospital, giving more focus to the research, she said. Initially, it will be
staffed by two employees.
"No longer will Providence be the first to simply make available current
medical therapies," Kucera said. "We will soon be involved in the design and
formation of medical science for the rest of the industry to follow."
Cunningham said that having more of a research emphasis may bring new
treatments to Central Texas. It is also sure to attract the best doctors and
staff in the nation, he said.
"These are the types of things people travel to places like the Mayo Clinic
and Boston for," Cunningham said. "Any bright, young gunner is going to be
excited about it. The kind of people we want to be on the front lines."